Validation of functional activity index in patients with rheumatoid arthritis (RAS)
https://doi.org/10.14412/1995-4484-2007-89-96
Abstract
Objective. To evaluate psychometric properties of Patient Activity Scale (PAS) index and possibility of its application for assessment of pt functional activity (PFA) and therapy efficacy in pts with rheumatoid arthritis (RA).
Material and methods. Validity assessment was performed on 454 pts with definite RA,mainly female (85,2%) with mean age 51,3±11,3 years, mean disease duration was 9,1±8,5 years, 59,7% of pts were seropositive on rheumatoid factor, most pts had moderate or high inflammatory activity of the disease (95,6%), II or III radiological stage ( 44,7% and 27,8% respectively, II (53,5%) or III (31,8%) functional class. Constructive validity of the index was assessed by calculation of coefficients of correlation with “external criteria”. Sensitivity was assessed with ACR criteria in 285 pts after 6 months of standard therapy. Reliability (reproducibility and internal constancy) were assessed in 92 pts in 3 days after admission.
Results. Assessment of PAS reliability with test-retest analysis did not reveal differences between first and repeat examination of pts whose state had not change after 3 days (mean scores 5,07±1,27 and 5,17±1,34 respectively, p=0,45). Intra-class Cronbach alpha coefficient was 0,95 (p<0,000001). Constructive validity assessment revealed moderate relationship of PFA with disease inflammatory activity measures: morning stiffness duration (r= 0,33, p<0,0000001), DAS 28 value (r=46, p<0,001), tender joint count (r=0,39, p<0,0000001), swollen joint count (r=0,28, p<0,0002) and weak relationship with ESR and radiological stage of the disease (r=0,17, p<0,00001). PAS correlation relationships with quality of life measures assessed on all SF-36 scales varied from -0,37 to -0,58. Index sensitivity to changes assessment showed that PAS change exceeding 0,22 corresponded to at least 20% health improvement according to ACR criteria.
Conclusion. PAS is a reliable, valid and sensitive instrument of pt functional state self assessment and can be used for dynamic evaluation of pts state and treatment efficacy in outpatient practice
About the Authors
V. N. AmirdjanovaRussian Federation
O. M. Folomeeva
Russian Federation
S. F. Erdes
Russian Federation
References
1. Олюнин Ю.А., Балабанова Р.М. Определение активности ревматоидного артрита в клинической практике. Тер.архив,2005,5,23-26
2. van Gestel A.M.,Andersson J.J.,van Riel P.L. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J.Rheumatol.,1999,26,705-711
3. Олюнин Ю.А. Определение активности воспалительного процесса и оценка эффективности системной и локальной терапии ревматоидного артрита. Дисс.д.м.н., 2007,223с
4. Fries J.F., Spitz P.W., Kraines R.G., Holman H.R. Measurement of patient outcome in arthritis . Arthr. Rheum., 1980, 23, 137-145
5. Pincus T., Strand V., Koch G. et al An index of the three core data set patient questionnaire measures distinguishes efficacy of treatment from of placebo as effectively as ACR 20% response criteria or the DAS in a rheumatoid arthritis clinical trial.Arthr. Rheum., 2003,48,625-630
6. Wolfe F., Michaud K.,Pincus T. A Composite Diseases Activity Scale for clinical practice,observational studies,and clinical trials:The Patient Activity Scale (PAS/PAS-II). J. Rheumatol., 2005, 32:12, 2410-2415
7. van der Heijde D.M.F.M.,van,t Hof M.A, vanRiel P.L.C.M, van Rijswijk M.N.,van de Putte L.B.A. Validity of single variables and composite indices for measuring diseases activity in rheumatoid arthritis. Ann.Rheum.Dis., 1992,51,177-181
8. Новик А.А., Ионова Т.И.. Руководство по исследованию качества жизни в медицине, С-Петербург, Олма-Пресс,2002, 300
9. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psycometrica, 1951, 16, 3, 297- 334
10. С.Гланц . Медико-биологическая статистика. «Практика», М.,1999,с194-199
11. Felson D.T.,Anderson J.J., Boers M. et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measires in Rheumatoid Arthritis Clinical Trials. Arthr.Rheum., 1993, 36,729-740
12. Smolen J.S. Report o the EULAR Standing Committee on Inrenational Clinical Studies Including Therapeutic Trials.Rheumatol.Eur.,1994,23,37-39
13. Felson D.T., Anderson J.J. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis (ACR- 20). Arthr. Rheum.,1995, 38, 727-35.
14. Steinbrocker O.,Traeger C.H., Batterman R.C. Therapeutic criteria in rheumatoid arthritis.J.Am. Med.Assoc., 1949,140,659-662
15. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey.Manual and interpretation gude. The Health Institute, New England Medical Center, Boston, Massachusets , 1993
Review
For citations:
Amirdjanova V.N., Folomeeva O.M., Erdes S.F. Validation of functional activity index in patients with rheumatoid arthritis (RAS). Rheumatology Science and Practice. 2007;45(4):89-96. https://doi.org/10.14412/1995-4484-2007-89-96
Email this article 